Amgen, Inc. (AMGN)
366.21
-1.58
(-0.43%)
USD |
NASDAQ |
Mar 13, 16:00
366.21
0.00 (0.00%)
After-Hours: 20:00
Amgen EPS Diluted (Quarterly) : 2.455 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Gilead Sciences, Inc. | 1.742 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.333B |
| Revenue (Quarterly) | 9.896B |
| Total Expenses (Quarterly) | 8.563B |
| Enterprise Value | 243.72B |
| Gross Profit Margin (Quarterly) | 81.91% |
| Profit Margin (Quarterly) | 13.47% |
| Earnings Yield | 3.89% |
| Operating Earnings Yield | 5.17% |
| Normalized Earnings Yield | 4.293 |